BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18316137)

  • 1. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
    Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
    J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S; Gow PJ; Vaughan RB; Angus PW
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.
    Hsieh WJ; Lin HC; Hwang SJ; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 1998 Jun; 93(6):962-6. PubMed ID: 9647029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without spontaneous bacterial peritonitis.
    Mustafa G; Khan M; Alam K; Rahman S; Ahmad N; Alam S; Ahmed S
    Hepatogastroenterology; 2007; 54(79):1905-7. PubMed ID: 18251125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.
    Sieper J; Fendler C; Laitko S; Sörensen H; Gripenberg-Lerche C; Hiepe F; Alten R; Keitel W; Groh A; Uksila J; Eggens U; Granfors K; Braun J
    Arthritis Rheum; 1999 Jul; 42(7):1386-96. PubMed ID: 10403266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
    Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
    Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
    Reuken PA; Pletz MW; Baier M; Pfister W; Stallmach A; Bruns T
    Aliment Pharmacol Ther; 2012 May; 35(10):1199-208. PubMed ID: 22449290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
    Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.
    Rimola A; Salmerón JM; Clemente G; Rodrigo L; Obrador A; Miranda ML; Guarner C; Planas R; Solá R; Vargas V
    Hepatology; 1995 Mar; 21(3):674-9. PubMed ID: 7875666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and microbiological characteristics of spontaneous bacterial peritonitis (SBP) in a recent five year period].
    Song HG; Lee HC; Joo YH; Jung S; Park YH; Ryu SH; Shin JW; Lee YJ; Chung YH; Lee YS; Suh DJ
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):61-70. PubMed ID: 12499818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
    Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
    Frazee LA; Marinos AE; Rybarczyk AM; Fulton SA
    Ann Pharmacother; 2005 May; 39(5):908-12. PubMed ID: 15769829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.
    Rolachon A; Cordier L; Bacq Y; Nousbaum JB; Franza A; Paris JC; Fratte S; Bohn B; Kitmacher P; Stahl JP
    Hepatology; 1995 Oct; 22(4 Pt 1):1171-4. PubMed ID: 7557868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.